Total Payments
$94,492
2024 Payments
$4,691
Companies
52
Transactions
824
Medicare Patients
59,937
Medicare Billing
$7.9M
Payment Breakdown by Category
Other$66,470 (70.3%)
Food & Beverage$24,351 (25.8%)
Travel$3,223 (3.4%)
Consulting$315.00 (0.3%)
Education$132.58 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $66,470 | 39 | 70.3% |
| Food and Beverage | $24,351 | 766 | 25.8% |
| Travel and Lodging | $3,223 | 12 | 3.4% |
| Consulting Fee | $315.00 | 2 | 0.3% |
| Education | $132.58 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $65,889 | 165 | $0 (2023) |
| Gilead Sciences, Inc. | $7,406 | 30 | $0 (2018) |
| Abbott Laboratories | $3,275 | 61 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,125 | 49 | $0 (2020) |
| CVRx, Inc. | $2,072 | 22 | $0 (2024) |
| ABIOMED | $1,747 | 33 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,681 | 80 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,159 | 31 | $0 (2024) |
| Merck Sharp & Dohme LLC | $770.06 | 36 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $713.54 | 53 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,691 | 100 | CVRx, Inc. ($1,241) |
| 2023 | $2,302 | 70 | W. L. Gore & Associates, Inc. ($316.40) |
| 2022 | $16,283 | 80 | Janssen Pharmaceuticals, Inc ($13,752) |
| 2021 | $12,065 | 123 | Janssen Pharmaceuticals, Inc ($9,943) |
| 2020 | $6,839 | 99 | Janssen Pharmaceuticals, Inc ($4,524) |
| 2019 | $14,386 | 113 | Janssen Pharmaceuticals, Inc ($12,002) |
| 2018 | $14,490 | 127 | Janssen Pharmaceuticals, Inc ($11,562) |
| 2017 | $23,435 | 112 | Janssen Pharmaceuticals, Inc ($14,073) |
All Payment Transactions
824 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: Heart Failure | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/07/2024 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $493.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $156.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $59.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $153.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $49.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $5.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Heart Failure | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $102.92 | General |
| Category: EndoVenous Therapies | ||||||
| 11/06/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $29.67 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $85.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Abbott Laboratories | ARMADA (Device) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Vascular | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $133.90 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/21/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $86.02 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/10/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/05/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $28.75 | General |
| Category: Cardiology | ||||||
| 10/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.86 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.39 | General |
| Category: Cardiovascular | ||||||
| 09/27/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 81 | 18,469 | 30,783 | $7.0M | $2.5M |
| 2022 | 69 | 14,461 | 24,202 | $4.8M | $1.8M |
| 2021 | 59 | 12,115 | 21,204 | $4.0M | $1.6M |
| 2020 | 59 | 14,892 | 23,530 | $4.6M | $1.9M |
Total Patients
59,937
Total Services
99,719
Medicare Billing
$7.9M
Procedure Codes
275
All Medicare Procedures & Services
275 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 3,443 | 6,005 | $1.5M | $539,116 | 35.2% |
| 36482 | Chemical destruction of first incompetent vein of arm or leg using imaging guidance | Office | 2023 | 98 | 238 | $880,362 | $313,257 | 35.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 1,884 | 1,966 | $786,139 | $286,653 | 36.5% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 294 | 298 | $406,174 | $194,610 | 47.9% |
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 52 | 52 | $514,488 | $173,868 | 33.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 664 | 672 | $262,080 | $95,850 | 36.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 465 | 2,315 | $148,160 | $79,254 | 53.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 581 | 581 | $192,311 | $63,570 | 33.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 324 | 424 | $162,392 | $61,144 | 37.7% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 742 | 744 | $132,432 | $51,032 | 38.5% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 283 | 2,318 | $122,854 | $45,198 | 36.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 106 | 107 | $99,510 | $36,863 | 37.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 93 | 187 | $51,051 | $33,029 | 64.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 487 | 507 | $91,260 | $31,431 | 34.4% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 206 | 1,545 | $81,885 | $29,857 | 36.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 157 | 158 | $78,526 | $27,791 | 35.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 185 | 196 | $76,832 | $26,712 | 34.8% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 19 | 31 | $78,027 | $26,238 | 33.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 2,482 | 2,569 | $74,501 | $26,169 | 35.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 127 | 127 | $76,200 | $25,738 | 33.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 302 | 922 | $55,320 | $20,747 | 37.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 238 | 312 | $48,048 | $17,962 | 37.4% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 104 | 188 | $47,000 | $17,674 | 37.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 35 | 40 | $46,480 | $17,638 | 37.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 95 | 375 | $46,500 | $17,614 | 37.9% |
About Dr. Fadi Atassi, MD
Dr. Fadi Atassi, MD is a Cardiovascular Disease healthcare provider based in Lake Havasu City, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1851553119.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fadi Atassi, MD has received a total of $94,492 in payments from pharmaceutical and medical device companies, with $4,691 received in 2024. These payments were reported across 824 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($66,470).
As a Medicare-enrolled provider, Atassi has provided services to 59,937 Medicare beneficiaries, totaling 99,719 services with total Medicare billing of $7.9M. Data is available for 4 years (2020–2023), covering 275 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Lake Havasu City, AZ
- Active Since 06/27/2008
- Last Updated 04/15/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1851553119
Products in Payments
- XARELTO (Drug) $65,889
- Ranexa (Drug) $7,152
- Barostim Neo System (Device) $2,072
- Impella (Device) $1,747
- Reveal LINQ (Device) $1,385
- ENTRESTO (Drug) $1,175
- UPTRAVI (Drug) $730.29
- ELIQUIS (Drug) $709.11
- CARDIOMEMS (Device) $699.18
- Repatha (Biological) $668.35
- LifeVest (Device) $644.18
- VERQUVO (Drug) $622.39
- LEQVIO (Drug) $506.31
- Fortify Assura, Ellipse ICD (Device) $373.75
- EXCLUDER Conformable AAA Endoprosthesis with Active Control (Device) $325.74
- BRILINTA (Drug) $314.56
- GORE VIABAHN VBX Balloon Expandable Endo (Device) $306.54
- XIENCE SIERRA (Device) $281.67
- Peripheral Orbital Atherectomy System (Device) $280.83
- Perclose ProGlide suture mediated closure system (Device) $257.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.